Global Veterinary Oncology Market to Reach $727.8 Million by 2030
The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet.
New York, May 03, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Veterinary Oncology Industry" - https://www.reportlinker.com/p06033237/?utm_source=GNW
Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.
Global Veterinary Oncology Market to Reach $727.8 Million by 2030
In the changed post COVID-19 business landscape, the global market for Veterinary Oncology estimated at US$233.6 Million in the year 2022, is projected to reach a revised size of US$727.8 Million by 2030, growing at aCAGR of 15.3% over the period 2022-2030. Chemotherapy, one of the segments analyzed in the report, is projected to record 16.8% CAGR and reach US$246 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Radiology segment is readjusted to a revised 13.5% CAGR for the next 8-year period.
The U.S. Market is Estimated at $63.6 Million, While China is Forecast to Grow at 19.9% CAGR
The Veterinary Oncology market in the U.S. is estimated at US$63.6 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$168 Million by the year 2030 trailing a CAGR of 19.9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.5% and 13.3% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 12% CAGR.
Select Competitors (Total 42 Featured)
- Accuray Incorporated
- Boehringer Ingelheim International GmbH
- Elanco
- Karyopharm Therapeutics, Inc.
- Morphogenesis, Inc.
- Nippon Zenyaku Kogyo Co., Ltd.
- One Health
- PetCure Oncology
- Regeneus Ltd.
- Varian Medical System, Inc.
Read the full report: https://www.reportlinker.com/p06033237/?utm_source=GNW
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Veterinary Oncology - Global Key Competitors Percentage Market
Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Veterinary Oncology by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2022 through 2030 and % CAGR
Table 2: World Historic Review for Veterinary Oncology by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR
Table 3: World 16-Year Perspective for Veterinary Oncology by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2014, 2023 & 2030
Table 4: World Recent Past, Current & Future Analysis for
Radiology by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2022 through 2030 and % CAGR
Table 5: World Historic Review for Radiology by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR
Table 6: World 16-Year Perspective for Radiology by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2014, 2023 & 2030
Table 7: World Recent Past, Current & Future Analysis for
Chemotherapy by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2022 through 2030 and % CAGR
Table 8: World Historic Review for Chemotherapy by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR
Table 9: World 16-Year Perspective for Chemotherapy by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
Table 10: World Recent Past, Current & Future Analysis for
Immunotherapy by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2022 through 2030 and % CAGR
Table 11: World Historic Review for Immunotherapy by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR
Table 12: World 16-Year Perspective for Immunotherapy by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
Table 13: World Recent Past, Current & Future Analysis for
Surgery by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2022 through 2030 and % CAGR
Table 14: World Historic Review for Surgery by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR
Table 15: World 16-Year Perspective for Surgery by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2014, 2023 & 2030
Table 16: World Recent Past, Current & Future Analysis for
Other Therapies by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2022 through 2030 and % CAGR
Table 17: World Historic Review for Other Therapies by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR
Table 18: World 16-Year Perspective for Other Therapies by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
Table 19: World Recent Past, Current & Future Analysis for
Canine by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2022 through 2030 and % CAGR
Table 20: World Historic Review for Canine by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR
Table 21: World 16-Year Perspective for Canine by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2014, 2023 & 2030
Table 22: World Recent Past, Current & Future Analysis for
Feline by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2022 through 2030 and % CAGR
Table 23: World Historic Review for Feline by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR
Table 24: World 16-Year Perspective for Feline by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2014, 2023 & 2030
Table 25: World Recent Past, Current & Future Analysis for
Lymphoma by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2022 through 2030 and % CAGR
Table 26: World Historic Review for Lymphoma by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR
Table 27: World 16-Year Perspective for Lymphoma by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2014, 2023 & 2030
Table 28: World Recent Past, Current & Future Analysis for Mast
Cell Cancer by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2022 through 2030 and % CAGR
Table 29: World Historic Review for Mast Cell Cancer by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR
Table 30: World 16-Year Perspective for Mast Cell Cancer by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
Table 31: World Recent Past, Current & Future Analysis for
Mammary & Squamous Cell Cancer by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
Table 32: World Historic Review for Mammary & Squamous Cell
Cancer by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR
Table 33: World 16-Year Perspective for Mammary & Squamous Cell
Cancer by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2014, 2023 &
2030
Table 34: World Recent Past, Current & Future Analysis for
Other Cancer Types by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2022 through 2030 and % CAGR
Table 35: World Historic Review for Other Cancer Types by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2014 through 2021 and % CAGR
Table 36: World 16-Year Perspective for Other Cancer Types by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
Table 37: World Veterinary Oncology Market Analysis of Annual
Sales in US$ Thousand for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
Veterinary Oncology Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United States for 2023 (E)
Table 38: USA Recent Past, Current & Future Analysis for
Veterinary Oncology by Therapy - Chemotherapy, Radiology,
Immunotherapy, Surgery and Other Therapies - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR
Table 39: USA Historic Review for Veterinary Oncology by
Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and
Other Therapies Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 40: USA 16-Year Perspective for Veterinary Oncology by
Therapy - Percentage Breakdown of Value Sales for Chemotherapy,
Radiology, Immunotherapy, Surgery and Other Therapies for the
Years 2014, 2023 & 2030
Table 41: USA Recent Past, Current & Future Analysis for
Veterinary Oncology by Animal Type - Canine and Feline -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 42: USA Historic Review for Veterinary Oncology by Animal
Type - Canine and Feline Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2014 through 2021 and %
CAGR
Table 43: USA 16-Year Perspective for Veterinary Oncology by
Animal Type - Percentage Breakdown of Value Sales for Canine
and Feline for the Years 2014, 2023 & 2030
Table 44: USA Recent Past, Current & Future Analysis for
Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell
Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 45: USA Historic Review for Veterinary Oncology by Cancer
Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell
Cancer and Other Cancer Types Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2014 through 2021 and %
CAGR
Table 46: USA 16-Year Perspective for Veterinary Oncology by
Cancer Type - Percentage Breakdown of Value Sales for Lymphoma,
Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other
Cancer Types for the Years 2014, 2023 & 2030
CANADA
Table 47: Canada Recent Past, Current & Future Analysis for
Veterinary Oncology by Therapy - Chemotherapy, Radiology,
Immunotherapy, Surgery and Other Therapies - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR
Table 48: Canada Historic Review for Veterinary Oncology by
Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and
Other Therapies Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 49: Canada 16-Year Perspective for Veterinary Oncology by
Therapy - Percentage Breakdown of Value Sales for Chemotherapy,
Radiology, Immunotherapy, Surgery and Other Therapies for the
Years 2014, 2023 & 2030
Table 50: Canada Recent Past, Current & Future Analysis for
Veterinary Oncology by Animal Type - Canine and Feline -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 51: Canada Historic Review for Veterinary Oncology by
Animal Type - Canine and Feline Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR
Table 52: Canada 16-Year Perspective for Veterinary Oncology by
Animal Type - Percentage Breakdown of Value Sales for Canine
and Feline for the Years 2014, 2023 & 2030
Table 53: Canada Recent Past, Current & Future Analysis for
Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell
Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 54: Canada Historic Review for Veterinary Oncology by
Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous
Cell Cancer and Other Cancer Types Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 55: Canada 16-Year Perspective for Veterinary Oncology by
Cancer Type - Percentage Breakdown of Value Sales for Lymphoma,
Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other
Cancer Types for the Years 2014, 2023 & 2030
JAPAN
Veterinary Oncology Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Japan for 2023 (E)
Table 56: Japan Recent Past, Current & Future Analysis for
Veterinary Oncology by Therapy - Chemotherapy, Radiology,
Immunotherapy, Surgery and Other Therapies - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR
Table 57: Japan Historic Review for Veterinary Oncology by
Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and
Other Therapies Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 58: Japan 16-Year Perspective for Veterinary Oncology by
Therapy - Percentage Breakdown of Value Sales for Chemotherapy,
Radiology, Immunotherapy, Surgery and Other Therapies for the
Years 2014, 2023 & 2030
Table 59: Japan Recent Past, Current & Future Analysis for
Veterinary Oncology by Animal Type - Canine and Feline -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 60: Japan Historic Review for Veterinary Oncology by
Animal Type - Canine and Feline Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR
Table 61: Japan 16-Year Perspective for Veterinary Oncology by
Animal Type - Percentage Breakdown of Value Sales for Canine
and Feline for the Years 2014, 2023 & 2030
Table 62: Japan Recent Past, Current & Future Analysis for
Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell
Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 63: Japan Historic Review for Veterinary Oncology by
Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous
Cell Cancer and Other Cancer Types Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 64: Japan 16-Year Perspective for Veterinary Oncology by
Cancer Type - Percentage Breakdown of Value Sales for Lymphoma,
Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other
Cancer Types for the Years 2014, 2023 & 2030
CHINA
Veterinary Oncology Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in China for 2023 (E)
Table 65: China Recent Past, Current & Future Analysis for
Veterinary Oncology by Therapy - Chemotherapy, Radiology,
Immunotherapy, Surgery and Other Therapies - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR
Table 66: China Historic Review for Veterinary Oncology by
Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and
Other Therapies Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 67: China 16-Year Perspective for Veterinary Oncology by
Therapy - Percentage Breakdown of Value Sales for Chemotherapy,
Radiology, Immunotherapy, Surgery and Other Therapies for the
Years 2014, 2023 & 2030
Table 68: China Recent Past, Current & Future Analysis for
Veterinary Oncology by Animal Type - Canine and Feline -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 69: China Historic Review for Veterinary Oncology by
Animal Type - Canine and Feline Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR
Table 70: China 16-Year Perspective for Veterinary Oncology by
Animal Type - Percentage Breakdown of Value Sales for Canine
and Feline for the Years 2014, 2023 & 2030
Table 71: China Recent Past, Current & Future Analysis for
Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell
Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 72: China Historic Review for Veterinary Oncology by
Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous
Cell Cancer and Other Cancer Types Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 73: China 16-Year Perspective for Veterinary Oncology by
Cancer Type - Percentage Breakdown of Value Sales for Lymphoma,
Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other
Cancer Types for the Years 2014, 2023 & 2030
EUROPE
Veterinary Oncology Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Europe for 2023 (E)
Table 74: Europe Recent Past, Current & Future Analysis for
Veterinary Oncology by Geographic Region - France, Germany,
Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2022 through 2030 and % CAGR
Table 75: Europe Historic Review for Veterinary Oncology by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 76: Europe 16-Year Perspective for Veterinary Oncology by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2014, 2023 & 2030
Table 77: Europe Recent Past, Current & Future Analysis for
Veterinary Oncology by Therapy - Chemotherapy, Radiology,
Immunotherapy, Surgery and Other Therapies - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR
Table 78: Europe Historic Review for Veterinary Oncology by
Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and
Other Therapies Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 79: Europe 16-Year Perspective for Veterinary Oncology by
Therapy - Percentage Breakdown of Value Sales for Chemotherapy,
Radiology, Immunotherapy, Surgery and Other Therapies for the
Years 2014, 2023 & 2030
Table 80: Europe Recent Past, Current & Future Analysis for
Veterinary Oncology by Animal Type - Canine and Feline -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 81: Europe Historic Review for Veterinary Oncology by
Animal Type - Canine and Feline Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR
Table 82: Europe 16-Year Perspective for Veterinary Oncology by
Animal Type - Percentage Breakdown of Value Sales for Canine
and Feline for the Years 2014, 2023 & 2030
Table 83: Europe Recent Past, Current & Future Analysis for
Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell
Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 84: Europe Historic Review for Veterinary Oncology by
Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous
Cell Cancer and Other Cancer Types Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 85: Europe 16-Year Perspective for Veterinary Oncology by
Cancer Type - Percentage Breakdown of Value Sales for Lymphoma,
Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other
Cancer Types for the Years 2014, 2023 & 2030
FRANCE
Veterinary Oncology Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in France for 2023 (E)
Table 86: France Recent Past, Current & Future Analysis for
Veterinary Oncology by Therapy - Chemotherapy, Radiology,
Immunotherapy, Surgery and Other Therapies - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR
Table 87: France Historic Review for Veterinary Oncology by
Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and
Other Therapies Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 88: France 16-Year Perspective for Veterinary Oncology by
Therapy - Percentage Breakdown of Value Sales for Chemotherapy,
Radiology, Immunotherapy, Surgery and Other Therapies for the
Years 2014, 2023 & 2030
Table 89: France Recent Past, Current & Future Analysis for
Veterinary Oncology by Animal Type - Canine and Feline -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 90: France Historic Review for Veterinary Oncology by
Animal Type - Canine and Feline Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR
Table 91: France 16-Year Perspective for Veterinary Oncology by
Animal Type - Percentage Breakdown of Value Sales for Canine
and Feline for the Years 2014, 2023 & 2030
Table 92: France Recent Past, Current & Future Analysis for
Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell
Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 93: France Historic Review for Veterinary Oncology by
Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous
Cell Cancer and Other Cancer Types Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 94: France 16-Year Perspective for Veterinary Oncology by
Cancer Type - Percentage Breakdown of Value Sales for Lymphoma,
Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other
Cancer Types for the Years 2014, 2023 & 2030
GERMANY
Veterinary Oncology Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Germany for 2023 (E)
Table 95: Germany Recent Past, Current & Future Analysis for
Veterinary Oncology by Therapy - Chemotherapy, Radiology,
Immunotherapy, Surgery and Other Therapies - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR
Table 96: Germany Historic Review for Veterinary Oncology by
Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and
Other Therapies Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 97: Germany 16-Year Perspective for Veterinary Oncology
by Therapy - Percentage Breakdown of Value Sales for
Chemotherapy, Radiology, Immunotherapy, Surgery and Other
Therapies for the Years 2014, 2023 & 2030
Table 98: Germany Recent Past, Current & Future Analysis for
Veterinary Oncology by Animal Type - Canine and Feline -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 99: Germany Historic Review for Veterinary Oncology by
Animal Type - Canine and Feline Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR
Table 100: Germany 16-Year Perspective for Veterinary Oncology
by Animal Type - Percentage Breakdown of Value Sales for Canine
and Feline for the Years 2014, 2023 & 2030
Table 101: Germany Recent Past, Current & Future Analysis for
Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell
Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 102: Germany Historic Review for Veterinary Oncology by
Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous
Cell Cancer and Other Cancer Types Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 103: Germany 16-Year Perspective for Veterinary Oncology
by Cancer Type - Percentage Breakdown of Value Sales for
Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and
Other Cancer Types for the Years 2014, 2023 & 2030
ITALY
Table 104: Italy Recent Past, Current & Future Analysis for
Veterinary Oncology by Therapy - Chemotherapy, Radiology,
Immunotherapy, Surgery and Other Therapies - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR
Table 105: Italy Historic Review for Veterinary Oncology by
Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and
Other Therapies Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 106: Italy 16-Year Perspective for Veterinary Oncology by
Therapy - Percentage Breakdown of Value Sales for Chemotherapy,
Radiology, Immunotherapy, Surgery and Other Therapies for the
Years 2014, 2023 & 2030
Table 107: Italy Recent Past, Current & Future Analysis for
Veterinary Oncology by Animal Type - Canine and Feline -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 108: Italy Historic Review for Veterinary Oncology by
Animal Type - Canine and Feline Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR
Table 109: Italy 16-Year Perspective for Veterinary Oncology by
Animal Type - Percentage Breakdown of Value Sales for Canine
and Feline for the Years 2014, 2023 & 2030
Table 110: Italy Recent Past, Current & Future Analysis for
Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell
Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 111: Italy Historic Review for Veterinary Oncology by
Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous
Cell Cancer and Other Cancer Types Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR
Table 112: Italy 16-Year Perspective for Veterinary Oncology by
Cancer Type - Percentage Breakdown of Value Sales for Lymphoma,
Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other
Cancer Types for the Years 2014, 2023 & 2030
UNITED KINGDOM
Veterinary Oncology Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United Kingdom for 2023 (E)
Table 113: UK Recent Past, Current & Future Analysis for
Veterinary Oncology by Therapy - Chemotherapy, Radiology,
Immunotherapy, Surgery and Other Therapies - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR
Table 114: UK Historic Review for Veterinary Oncology by
Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and
Other Therapies Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 115: UK 16-Year Perspective for Veterinary Oncology by
Therapy - Percentage Breakdown of Value Sales for Chemotherapy,
Radiology, Immunotherapy, Surgery and Other Therapies for the
Years 2014, 2023 & 2030
Table 116: UK Recent Past, Current & Future Analysis for
Veterinary Oncology by Animal Type - Canine and Feline -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 117: UK Historic Review for Veterinary Oncology by Animal
Type - Canine and Feline Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2014 through 2021 and %
CAGR
Table 118: UK 16-Year Perspective for Veterinary Oncology by
Animal Type - Percentage Breakdown of Value Sales for Canine
and Feline for the Years 2014, 2023 & 2030
Table 119: UK Recent Past, Current & Future Analysis for
Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell
Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 120: UK Historic Review for Veterinary Oncology by Cancer
Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell
Cancer and Other Cancer Types Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2014 through 2021 and %
CAGR
Table 121: UK 16-Year Perspective for Veterinary Oncology by
Cancer Type - Percentage Breakdown of Value Sales for Lymphoma,
Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other
Cancer Types for the Years 2014, 2023 & 2030
SPAIN
Table 122: Spain Recent Past, Current & Future Analysis for
Veterinary Oncology by Therapy - Chemotherapy, Radiology,
Immunotherapy, Surgery and Other Therapies - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR
Table 123: Spain Historic Review for Veterinary Oncology by
Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and
Other Therapies Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2014 through 2021 and % CAGR
Table 124: Spain 16-Year Perspective for Veterinary Oncology by
Therapy - Percentage Breakdown of Value Sales for Chemotherapy,
Radiology, Immunotherapy, Surgery and Other Therapies for the
Years 2014, 2023 & 2030
Table 125: Spain Recent Past, Current & Future Analysis for
Veterinary Oncology by Animal Type - Canine and Feline -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 126: Spain Historic Review for Veterinary Oncology by
Animal Type - Canine and Feline Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR
Table 127: Spain 16-Year Perspective for Veterinary Oncology by
Animal Type - Percentage Breakdown of Value Sales for Canine
and Feline for the Years 2014, 2023 & 2030
Table 128: Spain Recent Past, Current & Future Analysis for
Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell
Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types -
Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06033237/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001
